Direct Messaging Not Yet Widely Adopted by Physicians

Share this content:
Direct Messaging Not Yet Widely Adopted by Physicians
Direct Messaging Not Yet Widely Adopted by Physicians

TUESDAY, June 16, 2015 (HealthDay News) -- Direct secure messaging (Direct), which is a standardized protocol for exchanging clinical messages and attachments, has not been widely adopted by physicians, despite its potential for improving care coordination, according to an article published in Medical Economics.

Despite government promotion of the secure messaging protocol, there has been slow uptake of Direct. The latest electronic health record certification requires Direct messaging capability, but physicians who use Direct seem to be doing so mainly to meet meaningful use incentives.

According to the article, barriers to Direct include lack of education about the technology, costs, and technical difficulties such as only accepting messages that have attachments in a specific format. Physicians must have a Direct address to receive messages and the Direct address of their trading partners, but finding addresses can be challenging. Direct allows for fast and easy communication, but much of the communication already takes place via e-faxes, which are encrypted and Health Insurance Portability and Accountability Act (HIPAA)-compliant. However, Direct messages are more secure and fall under the HIPAA security rule as well as the privacy rule. Secure texting via Direct allows easy communication with other specialists and follow-up of patients.

"The lesson of secure texting is that when a new technology is simple to use and meets an immediate need, physicians will use it," according to the article. "Direct messaging is nowhere near as intuitive and simple as regular e-mail or Facebook."

Full Text

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Permits Marketing of Brain Stimulation Device for OCD

FDA Permits Marketing of Brain Stimulation Device for ...

FDA previously approved transcranial magnetic stimulation for major depression, certain migraines

Comments Open on End of NIH Review for Gene Therapy Studies

Comments Open on End of NIH Review for ...

NIH oversight panel no longer plans to review all applications for gene therapy experiments

U.S. Measles Outbreak Hits 107 Cases in 21 States, D.C.

U.S. Measles Outbreak Hits 107 Cases in 21 ...

Outbreak on track to exceed last year's; most of the people who got measles weren't vaccinated

is free, fast, and customized just for you!




Already a member?

Sign In Now »